Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 51-60 of 126 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Spatiotemporal transmission dynamics of hemorrhagic fever with renal syndrome in China, 2005–2012Zhang, W.; Wang, L.; Liu, Y.; Yin, W.; Hu, W.; Magalhaes, R.; Ding, F.; Sun, H.; Zhou, H.; Li, S.; Haque, U.; Tong, S.; Glass, G.; Bi, P.; Clements, A.; Liu, Q.; Li, C.; Bausch, D.
2014Individual characteristics associated with physical activity intervention delivery mode preferences among adultsShort, C.; Vandelanotte, C.; Duncan, M.
2014The effects of ageing and visual field loss on pointing to visual targetsRubinstein, N.; Anderson, A.; Ma-Wyatt, A.; Walland, M.; McKendrick, A.; Bex, P.
2014A 16-year prospective study of community-onset bacteremic Acinetobacter pneumoniaDavis, J.; McMillan, M.; Swaminathan, A.; Kelly, J.; Piera, K.; Baird, R.; Currie, B.; Anstey, N.
2014Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsYeung, D.; Mauro, M.
2014LgG4 immunostaining and its implications in orbital inflammatory diseaseWong, A.; Planck, S.; Choi, D.; Harrington, C.; Troxell, M.; Houghton, D.; Stauffer, P.; Wilson, D.; Grossniklaus, H.; Dailey, R.; Ng, J.; Steele, E.; Harris, G.; Czyz, C.; Foster, J.; White, V.; Dolman, P.; Kazim, M.; Patel, P.; Edward, D.; et al.; Wallace, G.
2014IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylationSmith, E.; Ruszkiewicz, A.; Jamieson, G.; Drew, P.
2014Haptoglobin duplicon, hemoglobin, and vitamin C: analyses in the British Women's Heart and Health Study and Caerphilly Prospective StudyGuthrie, P.; Abdollahi, M.; Gaunt, T.; Lawlor, D.; Ben-Shlomo, Y.; Gallacher, J.; Smith, G.; Day, I.; Rodriguez, S.
2014Is interpregnancy interval associated with cardiovascular risk factors in later life? A cohort studyKnipe, D.; Fraser, A.; Lawlor, D.; Howe, L.
2014Added value of soluble tumor necrosis factor-alpha receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetesForsblom, C.; Moran, J.; Harjutsalo, V.; Loughman, T.; Waden, J.; Tolonen, N.; Thorn, L.; Saraheimo, M.; Gordin, D.; Groop, P.; Thomas, M.